Fulminant Giant Cell Myocarditis following Heterologous Vaccination of ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19.

A 48-year-old female patient underwent a heart transplantation for acute fulminant myocarditis, following heterologous vaccination with the ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19. She had no history of severe acute respiratory syndrome coronavirus-2 infection. She did not exhibit clinical signs or have laboratory findings of concomitant infection before or after vaccination. Heart transplantation was performed because her heart failed to recover with venoarterial extracorporeal oxygenation support. Organ autopsy revealed giant cell myocarditis, possibly related to the vaccines. Clinicians may have to consider the possibility of the development of giant cell myocarditis, especially in patients with rapidly deteriorating cardiac function and myocarditis symptoms after COVID-19 vaccination.

ZnO nanosheets decorated with CdSe and TiO2 for the architecture of dye-sensitized solar cells.

Pure and TiO2- and CdSe-deposited ZnO nanosheets aligned vertically to the surface of ITO (Indium tin oxide) are prepared using electrodeposition, which is used for building blocks of dye sensitized solar cell. A significant improvement in the photovoltaic efficiency can be obtained by depositing TiO2 or CdSe on ZnO. Photoluminescence spectra show that the TiO2 and CdSe nanostructures suppress the recombination of the electron-hole pair of ZnO. We suggest that the interface charge transfer at TiO2-ZnO and CdSe-ZnO should be responsible for the suppression of the electron-hole pair recombination and enhanced solar cell efficiency by TiO2 and CdSe nanostructures.